← Back to patent-cliff list
CAS 13094-51-4
2-bromoacetic anhydride2-Bromoacetyl 2-bromoacetateBromoacetic anhydride
Codes: DABI-026, Ketoconazole-014, Bromfenac Sodium-022
Application context (from source-drug indications)
Venous thromboembolismDabigatran Etexilate MesylateEmbolismDabigatran Etexilate MesylateStrokeDabigatran Etexilate MesylateIschaemic strokeDabigatran Etexilate MesylatePulmonary embolismDabigatran Etexilate MesylateVenous thrombosisDabigatran Etexilate MesylateFungal infectionNaftifine hydrochloride/KetoconazoleCushing's syndromeKetoconazole头皮屑KetoconazolePityriasis versicolorKetoconazole皮肤念珠菌病KetoconazoleTineaKetoconazole脂溢性皮炎KetoconazoleInflammatory diseaseBromfenac SodiumPostoperative painBromfenac Sodium眼睛发炎Bromfenac Sodium眼睛疼痛Bromfenac SodiumDry eye syndromeBromfenac Sodium黄斑水肿Bromfenac Sodium
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Dabigatran Etexilate Mesylate | Tier B — Position early | - |
| Naftifine hydrochloride/Ketoconazole | Tier C — Watch / trade | - |
| Ketoconazole | Tier C — Watch / trade | - |
| Bromfenac Sodium | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate→hexyl (E)-(amino(4-aminophenyl)methylene)carbamate hydrochloride→2-bromoacetic anhydride→ethyl 3-(3-(2-bromoacetamido)-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate
1,3-Dichlorobenzene→2-Bromoacetyl 2-bromoacetate→2-Bromoacetyl bromide→2-Bromo-1-(2,4-dichlorophenyl)ethanone→1,3-Diaza-2,4-cyclopentadiene→1-(2,4-Dichlorophenyl)-2-imidazolylethanone→1-[4-(4-Hydroxyphenyl)piperazin-1-yl]ethanone→(+/-)-2-(Chloromethyl)oxirane→1-[4-[4-(2,3-Dihydroxypropoxy)phenyl]piperazin-1-yl]ethan-1-one
1,3-Dichlorobenzene→2-Bromoacetyl 2-bromoacetate→2-Bromoacetyl bromide→2-Bromo-1-(2,4-dichlorophenyl)ethanone→1,3-Diaza-2,4-cyclopentadiene→1-(2,4-Dichlorophenyl)-2-imidazolylethanone→1-[4-(4-Hydroxyphenyl)piperazin-1-yl]ethanone→(+/-)-2-(Chloromethyl)oxirane→1-[4-[4-(2,3-Dihydroxypropoxy)phenyl]piperazin-1-yl]ethan-1-one
2-Amino-4'-bromobenzophenone→N-[2-(4-Bromobenzoyl)phenyl]acetamide→2-Bromoacetyl bromide→2-Chloroacetyl chloride→Bromoacetic anhydride→Chloroacetic anhydride→N-Acetyl-2-bromo-N-[2-(4-bromobenzoyl)phenyl]acetamide→N-Acetyl-N-[2-(4-bromobenzoyl)phenyl]-2-chloroacetamide→1-Acetyl-7-(4-bromobenzoyl)-1,3-dihydro-2H-indol-2-one
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications | Action |
|---|---|---|---|---|---|---|
| Qualified Partner — East China API Works | Dabigatran etexilate mesylate Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Nantong cGMP Site | ethyl N-[3-amino-4-(methylamino)benzoyl]-N-pyridin-2-yl-beta-alaninate Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Taizhou GMP-like Site | N-(4-cyanophenyl)-Glycine Pharmaceutical Intermediates | On request | On request | On request | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.